These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4977698)

  • 1. Inhibition of the long-acting thyroid stimulator (LATS) by soluble thyroid fractions.
    Beall G; Doniach D; Roitt I; el Kabir D
    J Lab Clin Med; 1969 Jun; 73(6):988-99. PubMed ID: 4977698
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
    Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
    Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the thyroid gland component inhibiting LATS.
    Schleusener H; Murthy PV; McKenzie JM
    Metabolism; 1971 Mar; 20(3):299-308. PubMed ID: 4993770
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
    Amino N; Miyai K; Azukizawa M; Kumahara Y
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions.
    Berumen FO; Lobsenz IL; Utiger RD
    J Lab Clin Med; 1967 Oct; 70(4):640-9. PubMed ID: 6072404
    [No Abstract]   [Full Text] [Related]  

  • 6. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification and characterization of long-acting thyroid stimulator inhibiting factor from human thyroid tissues.
    Sato S; Noguchi S; Noguchi A
    Biochim Biophys Acta; 1972 Jul; 273(2):299-307. PubMed ID: 4673110
    [No Abstract]   [Full Text] [Related]  

  • 8. LATS inhibition by a soluble lipoprotein from human thyroid gland.
    Chopra IJ; Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1971 Jun; 32(6):772-8. PubMed ID: 5577160
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between LATS and thyroidal protein.
    Kendall-Taylor P; Munro DS; Smith BR
    Proc R Soc Med; 1971 Dec; 64(12):1267-8. PubMed ID: 5131284
    [No Abstract]   [Full Text] [Related]  

  • 10. The interaction between LATS and thyroid tissue in vitro.
    Smith BR; Munro DS
    Clin Sci; 1969 Oct; 37(2):566. PubMed ID: 5359011
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial purification of the binding activity for the long-acting thyroid stimulator in the human thyroid.
    Dirmikis S; Munro DS
    J Endocrinol; 1972 Nov; 55(2):xlv-xlvi. PubMed ID: 4636369
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
    Benhamou-Glynn N
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
    Mori T; Fisher J; Kriss JP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
    [No Abstract]   [Full Text] [Related]  

  • 17. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
    Strumia E
    Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids.
    Field JB; Remer A; Bloom G; Kriss JP
    J Clin Invest; 1968 Jul; 47(7):1553-60. PubMed ID: 5658587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro.
    Smith BR
    J Endocrinol; 1970 Jan; 46(1):45-54. PubMed ID: 5412406
    [No Abstract]   [Full Text] [Related]  

  • 20. ["Long-acting thyroid stimulator" (LATS)].
    Lamberg BA
    Duodecim; 1969; 85(20):1253-6. PubMed ID: 5396113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.